Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2386411
Max Phase: Preclinical
Molecular Formula: C26H31NO5
Molecular Weight: 437.54
Molecule Type: Small molecule
Associated Items:
ID: ALA2386411
Max Phase: Preclinical
Molecular Formula: C26H31NO5
Molecular Weight: 437.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN1C/C(=C\c2ccc(OC)c(OC)c2)C(=O)/C(=C/c2ccc(OC)c(OC)c2)C1
Standard InChI: InChI=1S/C26H31NO5/c1-6-11-27-16-20(12-18-7-9-22(29-2)24(14-18)31-4)26(28)21(17-27)13-19-8-10-23(30-3)25(15-19)32-5/h7-10,12-15H,6,11,16-17H2,1-5H3/b20-12+,21-13+
Standard InChI Key: UEVDRQYVQBOZRP-ZIOPAAQOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 437.54 | Molecular Weight (Monoisotopic): 437.2202 | AlogP: 4.48 | #Rotatable Bonds: 8 |
Polar Surface Area: 57.23 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.61 | CX LogP: 4.53 | CX LogD: 4.52 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.57 | Np Likeness Score: -0.35 |
1. Wu J, Zhang Y, Cai Y, Wang J, Weng B, Tang Q, Chen X, Pan Z, Liang G, Yang S.. (2013) Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents., 21 (11): [PMID:23611769] [10.1016/j.bmc.2013.03.057] |
2. Chen L, Li Q, Weng B, Wang J, Zhou Y, Cheng D, Sirirak T, Qiu P, Wu J.. (2018) Design, synthesis, anti-lung cancer activity, and chemosensitization of tumor-selective MCACs based on ROS-mediated JNK pathway activation and NF-κB pathway inhibition., 151 [PMID:29655083] [10.1016/j.ejmech.2018.03.051] |
Source(1):